Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:09 pm Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | VANGUARD GROUP INC | 9,710,328 9.88% | 370,033 (+3.96%) | View |
| 2024-01-23 11:52 am Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | BlackRock Inc. BLK | 13,647,679 13.9% | 1,020,276 (+8.08%) | View |
| 2023-02-24 06:15 am Purchase | 13D | VOYAGER THERAPEUTICS INC VYGR | NEUROCRINE BIOSCIENCES INC NBIX | 8,575,316 19.9% | 4,395,588 (+105.16%) | View |
| 2023-02-09 11:27 am Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | VANGUARD GROUP INC | 9,340,295 9.72% | 552,304 (+6.28%) | View |
| 2023-02-09 11:05 am Sale | 13G | NEUROCRINE BIOSCIENCES INC NBIX | JANUS HENDERSON GROUP PLC JHG | 2,415,638 2.5% | -5,030,201 (-67.56%) | View |
| 2023-01-23 3:52 pm Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | BlackRock Inc. BLK | 12,627,403 13.1% | 1,150,858 (+10.03%) | View |
| 2022-02-14 2:34 pm Sale | 13G | NEUROCRINE BIOSCIENCES INC NBIX | PRICE T ROWE ASSOCIATES INC | 4,359,645 4.5% | -1,912,085 (-30.49%) | View |
| 2022-02-10 4:46 pm Sale | 13G | NEUROCRINE BIOSCIENCES INC NBIX | JANUS HENDERSON GROUP PLC JHG | 7,445,839 7.8% | -1,998,282 (-21.16%) | View |
| 2022-02-10 08:27 am Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | VANGUARD GROUP INC | 8,787,991 9.26% | 450,726 (+5.41%) | View |
| 2022-01-27 1:59 pm Unchanged | 13G | NEUROCRINE BIOSCIENCES INC NBIX | BlackRock Inc. BLK | 11,476,545 12.1% | 0 (Unchanged) | View |
| 2022-01-25 6:45 pm Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | BlackRock Inc. BLK | 11,476,545 12.1% | 486,899 (+4.43%) | View |
| 2021-08-10 10:33 am Sale | 13G | NEUROCRINE BIOSCIENCES INC NBIX | FMR LLC | 3,780,076 3.994% | -4,656,553 (-55.19%) | View |
| 2021-04-12 2:46 pm Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | JANUS HENDERSON GROUP PLC JHG | 9,444,121 10% | 136,201 (+1.46%) | View |
| 2021-04-09 6:00 pm Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | BlackRock Inc. BLK | 10,989,646 11.7% | 3,991,851 (+57.04%) | View |
| 2021-02-16 4:04 pm Sale | 13G | NEUROCRINE BIOSCIENCES INC NBIX | Capital International Investors | 4,049,442 4.3% | -2,690,977 (-39.92%) | View |
| 2021-02-16 12:23 pm Sale | 13G | NEUROCRINE BIOSCIENCES INC NBIX | PRICE T ROWE ASSOCIATES INC | 6,271,730 6.7% | -1,019,567 (-13.98%) | View |
| 2021-02-11 4:55 pm Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | JANUS HENDERSON GROUP PLC JHG | 9,307,920 9.9% | 1,934,408 (+26.23%) | View |
| 2021-02-10 11:28 am Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | VANGUARD GROUP INC | 8,337,265 8.92% | 20,368 (+0.24%) | View |
| 2021-02-08 10:29 am Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | FMR LLC | 8,436,629 9.022% | 1,005,256 (+13.53%) | View |
| 2021-01-29 5:23 pm Purchase | 13G | NEUROCRINE BIOSCIENCES INC NBIX | BlackRock Inc. BLK | 6,997,795 7.5% | 406,243 (+6.16%) | View |